Skip to main content
Equibles

GMAB · Genmab A/S · Held by Funds

Track GMAB — free

Use GMAB with AI

Add company filings, earnings and prices to ChatGPT or Claude, then ask questions in your own chat.

Choose your app for step-by-step connection instructions. Sign in with Equibles when asked; no code or API key is needed.

Claude ChatGPT

After connecting, ask your AI to use Equibles to research GMAB.

Other apps & server URL
https://mcp.equibles.com/mcp
Gemini CLI setup
or ask here

Free, nothing to set up — ALVIS runs on the same tools and cites every figure.

See what you can ask in ChatGPT or Claude

All connection guides →
$51.37 -0.37 (-0.72%) At close · Nov 13 Play latest call Q3 2026 earnings call transcript
Rebalance outlook locked
Market Cap
$31.67B
Shares
616.59M
Volume · Nov 13 3.73M Avg daily vol (3M) 4.21M

Registered funds — mutual funds, ETFs and closed-end funds — whose latest Form N-PORT portfolio report holds this exact listed security, matched by CUSIP. Each row is one fund position with its size, value and weight in that fund.

Fund Ownership of GMAB by Fund Type

Registered funds' Form N-PORT reports for the quarter ended Jun 30, 2026

Index funds and index ETFs hold 1.05% of shares outstanding.

Fund type Of shares outstanding Shares
Index funds 0.01% 46,361
Index ETFs 1.04% 6,419,882
Active ETFs 0.04% 251,014
Active funds 0.73% 4,506,100
Unclassified 0.11% 656,949
All registered funds 1.93% 11,880,306
How fund types are measured

Each fund series counts once, with its latest Form N-PORT report dated inside the quarter; only long share positions count, restated to today's split basis. The fund type is the series' latest Form N-CEN answer on or before the quarter end (the index-fund box and the exchange-traded flag), never its name. Unclassified funds have no usable N-CEN; unit investment trusts are among them, so index ownership is a floor. Funds sit inside their advisers' 13F reports, so these shares overlap the 13F figures and are never added to them.

Funds holding GMAB

51 fund positions
Fund Balance Value % of Fund Open
iShares Biotechnology ETF 3,701,095 $101,669,080 1.12%
First Trust NYSE Arca Biotechnology Index Fund 2,686,600 $73,800,902 2.62%
AB LARGE CAP GROWTH FUND INC 1,692,412 $46,490,558 0.20%
Avantis International Equity ETF 546,778 $18,131,158 0.09%
Federated Hermes Kaufmann Fund 520,700 $15,032,609 0.31%
Federated Hermes International Leaders Fund 343,771 $11,399,446 0.77%
Federated Hermes Kaufmann Small Cap Fund 350,000 $10,104,500 0.35%
Tax-Managed U.S. Large Cap Fund 342,344 $9,883,471 0.08%
Tema Oncology ETF 183,357 $6,080,118 2.88%
Mercer Non-US Core Equity Fund 179,676 $4,935,700 0.10%
SA AB Growth Portfolio 161,398 $4,659,560 0.26%
LVIP AllianceBernstein Large Cap Growth Fund 157,566 $4,328,338 0.27%
AB Large Cap Growth Portfolio 106,807 $3,810,340 0.36%
Timothy Plan International Fund 137,000 $3,763,390 1.59%
U.S. Strategic Equity Fund 104,293 $3,010,939 0.10%
SIMT Large Cap Fund 82,643 $2,270,203 0.15%
LVIP Blended Large Cap Growth Managed Volatility Fund 77,209 $2,120,931 0.13%
SIMT Tax-Managed Large Cap Fund 72,944 $2,003,772 0.04%
Fidelity Nasdaq Composite Index Fund 60,288 $1,999,150 0.01%
First Trust Nasdaq BuyWrite Income ETF 63,413 $1,741,955 0.19%
Multi-Manager International Equity Strategies Fund 47,510 $1,575,432 0.05%
SIIT LARGE CAP DISCIPLINED EQUITY FUND 43,080 $1,428,533 0.11%
Strategic Advisers International Fund 38,964 $1,292,046 0.00%
International Developed Markets Select Equity ETF 43,586 $1,258,328 1.41%
Avantis International Equity Fund 35,483 $1,176,616 0.10%
ActivePassive International Equity ETF 32,968 $1,093,219 0.09%
Federated Hermes International Growth Fund 30,323 $1,005,511 0.84%
Fidelity Nasdaq Composite Index ETF 26,116 $866,007 0.01%
EQ/International Core Managed Volatility Portfolio 27,643 $759,353 0.06%
U.S. Strategic Equity Fund 22,592 $620,602 0.09%
Avantis International Large Cap Value ETF 17,483 $579,736 0.03%
Dimensional International Core Equity Market ETF 15,280 $441,134 0.00%
Equity Income Fund 11,762 $339,569 0.22%
Federated Hermes Kaufmann Fund II 11,372 $312,389 0.28%
Dimensional International Value ETF 9,780 $282,349 0.00%
Blackstone Alternative Multi-Strategy Fund 8,100 $222,507 0.01%
Avantis Responsible International Equity ETF 6,385 $211,727 0.06%
PRAXIS INTERNATIONAL INDEX FUND 6,790 $186,521 0.03%
Large Company Growth Portfolio 6,590 $181,027 0.06%
Invesco Nasdaq Biotechnology ETF 4,722 $156,582 0.16%
B.A.D. ETF 4,069 $155,802 1.44%
Range Cancer Therapeutics ETF 5,921 $134,288 1.50%
Adasina Social Justice All Cap Global ETF 3,497 $115,961 0.04%
ProShares Ultra Nasdaq Biotechnology 2,711 $89,897 0.09%
Dimensional International Core Equity 2 ETF 1,800 $51,966 0.00%
Defiance Nasdaq Junior Biotechnology ETF 1,105 $48,289 0.67%
LARGE CAP INTERNATIONAL PORTFOLIO 1,009 $29,130 0.00%
Federated Hermes International Leaders ETF 734 $21,191 0.68%
ProShares UltraPro Nasdaq Biotechnology 702 $15,992 0.08%
WisdomTree BioRevolution Fund 408 $11,208 0.42%
Showing 1–50 of 51 positions
Key facts CIK 1434265 CUSIP 372303206 13F (30d) 267 filings 237 filers Visit website Investor relations